These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24160960)

  • 1. Treatment of chronic noninfectious uveitis in children--the trend toward tumor necrosis factor-alpha inhibition.
    Cunningham ET
    J AAPOS; 2013 Oct; 17(5):451-3. PubMed ID: 24160960
    [No Abstract]   [Full Text] [Related]  

  • 2. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab therapy for refractory childhood uveitis.
    Bravo-Ljubetic L; Peralta-Calvo J; Noval S; Pastora-Salvador N; Abelairas-Gómez J; Merino R
    J AAPOS; 2013 Oct; 17(5):456-9. PubMed ID: 24160962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab in the therapy of uveitis in childhood.
    Mansour AM
    Br J Ophthalmol; 2007 Mar; 91(3):274-6. PubMed ID: 17322463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab and adalimumab for uveitis.
    Martel JN; Esterberg E; Nagpal A; Acharya NR
    Ocul Immunol Inflamm; 2012 Feb; 20(1):18-26. PubMed ID: 22324897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author reply: To PMID 24359625.
    Read RW; Levy-Clarke G; Jabs DA; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Oct; 121(10):e58-9. PubMed ID: 25015217
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96).
    Onal S; Tugal-Tutkun I
    Ophthalmology; 2014 Oct; 121(10):e57-8. PubMed ID: 25064722
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B; Saeed T; Situnayake RD; Murray PI
    Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
    Leclercq M; Le Besnerais M; Langlois V; Girszyn N; Benhamou Y; Ngo C; Levesque H; Muraine M; Gueudry J
    Clin Rheumatol; 2018 Mar; 37(3):849-853. PubMed ID: 29397459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
    Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT
    Br J Ophthalmol; 2013 Apr; 97(4):481-6. PubMed ID: 23376607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
    Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
    Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
    J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors.
    Lerman MA; Lewen MD; Kempen JH; Mills MD
    Am J Ophthalmol; 2015 Jul; 160(1):193-200.e1. PubMed ID: 25892124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-centre experience with adalimumab for the treatment of non-infectious uveitis.
    Dobner BC; Max R; Becker MD; Heinz C; Veltrup I; Heiligenhaus A; Barisani-Asenbauer T; Mackensen F
    Br J Ophthalmol; 2013 Feb; 97(2):134-8. PubMed ID: 23212204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses.
    Cordero-Coma M; Calleja S; Llorente M; Rodriguez E; Franco M; Ruiz de Morales JG
    Ocul Immunol Inflamm; 2013 Jun; 21(3):212-9. PubMed ID: 23617852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile of adalimumab and its potential in the treatment of uveitis.
    Balevic SJ; Rabinovich CE
    Drug Des Devel Ther; 2016; 10():2997-3003. PubMed ID: 27698552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study.
    Hamam RN; Barikian AW; Antonios RS; Abdulaal MR; Alameddine RM; El Mollayess G; Mansour AM
    Ocul Immunol Inflamm; 2016 Jun; 24(3):319-26. PubMed ID: 25549063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic uveitis responding to adalimumab therapy.
    Ermertcan AT; Emre S; Öztürk F; Gençoğlan G; Gündüz K
    Int J Dermatol; 2014 Apr; 53(4):e271-3. PubMed ID: 23879868
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab for the treatment of refractory acne conglobata.
    Sand FL; Thomsen SF
    JAMA Dermatol; 2013 Nov; 149(11):1306-7. PubMed ID: 24048280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.